Feng Bin, Qian Wen-wei, Weng Xi-sheng, Wang Wei, Zhao Li-juan, Jiang Chao
Department of Orthopaedic Surgery, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Apr;37(2):133-9. doi: 10.3881/j.issn.1000-503X.2015.02.001.
To evaluate the outcome of core decompression with bone impaction grafting for the treatment of osteonecrosis of femoral head.
Totally 39 cases (46 hips) of osteonecrosis of femoral head were treated with core decompression and impaction bone grafting. According to the Association Research Circulation Osseous (ARCO) system, 3 hips were graded for stage 1,16 for stage 2a,7 for 2b,11 for 2c, and 9 for 3.The Harris hip score (HHS) was evaluated before operation and at the latest follow-up.
In all these patients, 22 hips had hormone-related lesions, 11 had alcohol-related lesions, and 13 had idiopathic lesions. The average HHS was changed from (66 ± 6.6) before surgery to (80.2 ± 9.7) after surgery during an average follow-up of 26 months(from 9 to 48 months). The postoperative HHS showed no significant difference among osteonecrosis of femoral head due to different etiologies.Also,the postoperative HHS and clinical effectiveness were not significantly different among patients with different preoperative stages.The postoperative outcome was excellent in 7 cases, good in 23 cases, mild in 4 cases,and poor in 12 cases. The rate of excellent and good was 65% in this series,with 78% for patients with early stages and 52.6% for those with grade 2c or higher lesions. The femoral head collapsed in 7 cases,and 5 of which were preoperatively graded as in stage 2c and higher. The postoperative complications included intertrochanteric fracture (n=1) and infection (n=1). Four hips were converted to total hip arthroplasty. All of other hips had no obvious progression of osteonecrosis.
Core decompression with bone impaction allografting is effective for the treatment of osteonecrosis of femoral head. Patients with lesions in earlier ARCO stages can have better outcomes.
评估髓芯减压联合打压植骨治疗股骨头坏死的疗效。
采用髓芯减压联合打压植骨治疗39例(46髋)股骨头坏死患者。根据国际骨循环研究学会(ARCO)分期系统,其中1期3髋,2a期16髋,2b期7髋,2c期11髋,3期9髋。于术前及末次随访时评估Harris髋关节评分(HHS)。
所有患者中,22髋为激素相关性病变,11髋为酒精相关性病变,13髋为特发性病变。平均随访26个月(9至48个月),HHS评分由术前的(66±6.6)分提高至术后的(80.2±9.7)分。不同病因所致股骨头坏死患者术后HHS评分差异无统计学意义。不同术前分期患者术后HHS评分及临床疗效差异亦无统计学意义。术后疗效优7例,良23例,中4例,差12例。本组优良率为65%,早期患者为78%,2c期及以上患者为52.6%。7例出现股骨头塌陷,其中5例术前为2c期及以上。术后并发症包括转子间骨折1例、感染1例。4髋改行全髋关节置换术。其余所有髋关节股骨头坏死均无明显进展。
髓芯减压联合同种异体骨打压植骨治疗股骨头坏死有效。ARCO分期较早的患者疗效更佳。